Short answer

Female STI infertility is overwhelmingly tubal scarring from chlamydia and gonorrhea pelvic inflammatory disease. Silent, cumulative, preventable by screening and prompt treatment, and bypassable by IVF when established.

The tragedy embedded in the statistics is timing: most damage occurs without dramatic illness, discovered only years later at fertility workups.

Every element below serves one goal. Moving detection earlier than damage.

Continue with Painful Urination in Women: UTI or STI? for the directly connected guidance.

Advertisement

Sponsored: confidential STD testing with results in 1–2 days

Need a test? STDTest.online is education-only and does not provide testing. The banner above is a paid advertisement for an independent testing service. We may earn a commission if you use it, at no extra cost to you. Always confirm current prices, accreditation, and privacy terms on their website before ordering.

See Tests & Prices →

Mechanism map in detail

Ascending infection travels cervix → uterus → fallopian tubes (salpingitis), where inflammation scars delicate tubal architecture: endosalpingeal destruction impairs egg transport, tubal occlusion blocks egg-sperm meeting entirely, peritubal adhesions tether organs abnormally.

Partial damage creates ectopic pregnancy risk (embryos implanting in damaged tubes); complete damage creates infertility.

Subclinical PID, scarring without memorable illness, contributes substantially, which is why “I never had symptoms” never reassures at fertility workups.

Risk quantification that motivates screening

Post-PID tubal infertility runs roughly 10%+ after a single episode, climbing steeply with each repeat. Recurrent PID multiplies risk several-fold.

Population tubal-factor shares concentrate where screening lags: disparities reflect healthcare access gaps, not biology or behavior differences.

M.

genitalium contributes an emerging share.

Meanwhile HPV, herpes, trichomoniasis, and treated syphilis don’t meaningfully impair fertility. Precision here prevents both complacency (about chlamydia/gonorrhea) and unnecessary fear (about everything else).

Evaluation after trying thresholds

Standard thresholds (a year of trying under 35, six months over 35) shorten with STI/PID history. Disclose histories upfront to expedite tubal assessment.

  • Hysterosalpingography images tubal patency directly.
  • Ovarian reserve and ovulation assessment rule concurrent factors in or out.
  • Partner semen analysis (male factors coexist in a large minority. Evaluate both partners, never one).
  • Laparoscopy for complex cases visualizes adhesions directly.

Active STIs get treated before fertility treatment begins. Infection clearance is a prerequisite, not an afterthought.

Treatment pathways by damage extent

  • Tubal surgery (selected proximal or mild disease): reconstructive procedures restoring patency, best for limited damage in younger patients.
  • IVF (bilateral occlusion, severe disease): bypasses tubes entirely with excellent per-cycle success. The standard answer for established tubal-factor infertility.
  • Infection clearance first in all pathways.

Counseling covers timelines, costs, and emotional dimensions honestly; fertility treatment is demanding, and informed consent includes the full picture.

When to seek care

Before damage: screening on schedule and prompt PID treatment (fertility preservation in real time, at routine visits).

After trying thresholds: fertility evaluation (sooner with any STI/PID history. Say so at booking).

Urgently: ectopic warning signs (one-sided pain, bleeding) in early pregnancies with tubal risk factors.